Latest Period
Q2 2026
Security Snapshot
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) Institutional Ownership
CUSIP: 159864107
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
559
Shares (Excl. Options)
56,699,335
Price
$226.79
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- CRL on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 56,699,335
- Total 13F value
- $12,842,942,346
- Portfolio coverage rank
- 0.01%
- Share change
- -351,479
- Value change
- -$63,874,234
- Number of holders
- 559
- Shares outstanding
- 48,141,694
- SEC-reported price per share
- $234.62
- Insider filing price
- $234.62
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock is tracked under CUSIP 159864107.
- 559 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 554 to 559 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $9,864,259,716 to $12,842,942,346.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 559 institutions filings for Q2 2026.
Security key
159864107
Latest holder period
Q2 2026
13F holders
559
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
CRL full holder history
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC filings
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. company facts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 159864107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
CRL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 8.8% | +26% | $978,068,267 | +$180,747,230 | 4,239,751 | +23% | FMR LLC | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.4% | $626,929,860 | 3,634,376 | Vanguard Capital Management | 31 Mar 2026 | |||
| BlackRock, Inc. | 6.9% | $405,588,067 | 3,524,401 | BlackRock, Inc. | 31 Mar 2025 | |||
| Invesco Ltd. | 6.2% | +26% | $688,560,052 | +$135,537,988 | 2,984,785 | +25% | Invesco Ltd. | 30 Jun 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.6% | -41% | $383,060,155 | -$315,620,213 | 1,749,213 | -45% | Wellington Management Group LLP | 31 Dec 2025 |
| NOMURA HOLDINGS INC | 1.6% | -76% | $126,407,633 | -$293,166,299 | 807,923 | -70% | NOMURA HOLDINGS INC | 30 Sep 2025 |
As of 30 Jun 2026, 559 institutional investors reported holding 56,699,335 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL). This represents 118% of the company’s total 48,141,694 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
83%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 8.8% | 4,239,752 | +23% | 0.04% | $961,533,236 |
| BlackRock, Inc. | 7.9% | 3,798,560 | -1.6% | 0.01% | $861,475,349 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 3,149,288 | -1.7% | 0.02% | $714,227,026 |
| Invesco Ltd. | 6.2% | 2,984,785 | +25% | 0.05% | $676,919,391 |
| HARRIS ASSOCIATES L P | 4.7% | 2,241,144 | +4.1% | 0.68% | $508,269,048 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.6% | 2,210,979 | -3.6% | 0.02% | $501,427,927 |
| Allspring Global Investments Holdings, LLC | 4% | 1,905,247 | -4.4% | 0.67% | $436,473,035 |
| STATE STREET CORP | 3.9% | 1,864,284 | -0.5% | 0.01% | $422,800,968 |
| DIMENSIONAL FUND ADVISORS LP | 3.4% | 1,648,450 | -0.24% | 0.07% | $373,848,597 |
| ARIEL INVESTMENTS, LLC | 3.1% | 1,506,185 | +4.3% | 3.4% | $341,587,697 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.1% | 1,505,370 | +34% | 0.03% | $341,404,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 1,305,738 | +0% | 0.02% | $295,598,099 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.7% | 1,288,463 | -21% | 0.05% | $292,210,525 |
| CITADEL ADVISORS LLC | 2.5% | 1,193,601 | -1.5% | 0.16% | $270,696,771 |
| BANK OF AMERICA CORP /DE/ | 2.4% | 1,172,586 | +3.3% | 0.02% | $265,930,779 |
| EARNEST PARTNERS LLC | 2.3% | 1,120,011 | +15% | 0.92% | $254,007,295 |
| AMERIPRISE FINANCIAL INC | 1.8% | 881,189 | -21% | 0.04% | $199,834,979 |
| NEUBERGER BERMAN GROUP LLC | 1.8% | 862,704 | -1.3% | 0.13% | $195,633,630 |
| SEI INVESTMENTS CO | 1.7% | 813,530 | +7.4% | 0.16% | $184,499,540 |
| MORGAN STANLEY | 1.7% | 800,487 | -3% | 0.01% | $181,542,851 |
| Clearbridge Investments, LLC | 1.6% | 781,276 | +23% | 0.15% | $177,185,527 |
| COOKE & BIELER LP | 1.6% | 755,630 | -13% | 2% | $171,369,328 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.4% | 682,173 | -25% | 0.05% | $157,642,604 |
| VICTORY CAPITAL MANAGEMENT INC | 1.4% | 664,768 | -11% | 0.08% | $150,762,735 |
| UBS Group AG | 1.3% | 646,747 | -12% | 0.02% | $146,675,752 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 56,699,335 | $12,842,942,346 | -$63,874,234 | $226.79 | 559 |
| 2026 Q1 | 57,135,089 | $9,864,259,716 | +$737,419,908 | $172.50 | 554 |
| 2025 Q4 | 52,867,055 | $10,554,340,633 | +$591,811,031 | $199.48 | 578 |
| 2025 Q3 | 50,358,962 | $7,914,672,575 | -$81,951,872 | $156.46 | 548 |
| 2025 Q2 | 50,888,032 | $7,728,322,181 | -$310,858,917 | $151.73 | 512 |
| 2025 Q1 | 52,969,373 | $7,965,191,033 | -$132,450,866 | $150.52 | 556 |
| 2024 Q4 | 52,965,520 | $9,772,547,065 | +$141,580,661 | $184.60 | 629 |
| 2024 Q3 | 51,997,508 | $10,237,704,172 | +$106,573,857 | $196.97 | 620 |
| 2024 Q2 | 52,315,867 | $10,806,083,788 | -$50,431,113 | $206.58 | 652 |
| 2024 Q1 | 52,068,409 | $14,099,205,526 | +$83,751,736 | $270.95 | 663 |
| 2023 Q4 | 51,907,726 | $12,262,886,096 | +$33,773,620 | $236.40 | 626 |
| 2023 Q3 | 51,730,793 | $10,129,283,110 | +$137,477,111 | $195.98 | 613 |
| 2023 Q2 | 51,052,211 | $10,727,150,937 | +$46,431,278 | $210.25 | 606 |
| 2023 Q1 | 50,855,208 | $10,257,550,518 | +$230,104,905 | $201.82 | 610 |
| 2022 Q4 | 49,950,724 | $10,886,200,761 | -$62,906,975 | $217.90 | 616 |
| 2022 Q3 | 50,414,076 | $9,921,902,851 | +$280,780,236 | $196.80 | 566 |
| 2022 Q2 | 48,746,360 | $10,430,287,913 | +$210,876,421 | $213.97 | 612 |
| 2022 Q1 | 47,548,656 | $13,504,739,634 | +$68,014,953 | $283.97 | 631 |
| 2021 Q4 | 47,053,533 | $17,719,824,151 | +$122,176,357 | $376.78 | 696 |
| 2021 Q3 | 46,743,700 | $19,292,102,147 | -$322,317,303 | $412.67 | 663 |
| 2021 Q2 | 47,485,940 | $17,565,553,473 | +$159,923,840 | $369.92 | 626 |
| 2021 Q1 | 47,155,221 | $13,665,037,431 | +$124,076,612 | $289.83 | 555 |
| 2020 Q4 | 46,852,548 | $11,705,651,069 | +$64,724,684 | $249.86 | 533 |
| 2020 Q3 | 46,655,777 | $10,562,682,947 | +$28,508,177 | $226.45 | 487 |
| 2020 Q2 | 50,866,401 | $8,795,028,070 | +$54,062,078 | $174.35 | 457 |